Last 23 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.83 | 4.51 | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 0.00 | 1.35 | 1.48 | 2.32 | 1.93 | 1.14 | 1.67 | 0.58 | 0.48 | 0.58 | 0.65 | 0.85 | 3.07 | 3.26 | 2.24 | 3.75 | 2.75 | 5.03 | 15.21 | 143.03 | 152.95 |
| — | +18.5% | -11.3% | +301.1% | +302.5% | +97.1% | +154.4% | -31.8% | -84.4% | -82.3% | -70.8% | -77.3% | +11.7% | -35.2% | -85.2% | -97.4% | -98.2% | +50810.5% | -71.0% | +4025.5% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2.97 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -177.5% | -109.3% | -87.9% | -59.5% | -46.3% | -38.1% | -26.6% | -26.3% | -19.5% | -18.7% | -12.7% | -17.1% | -18.8% | -27.1% | -10.2% | -20.7% | -1.1% | 40.2% | 47.0% | -587.7% | -75.2% |
| — | -186.8% | -230.0% | -126.0% | -137.1% | -104.0% | -109.1% | -54.0% | -4.0% | +31.0% | -25.3% | +17.4% | -1566.2% | -167.3% | -121.6% | +96.5% | +98.5% | +210.7% | +2280.1% | -58699.9% | — | |
| ROA | -115.0% | -45.6% | -43.0% | -31.5% | -27.5% | -25.1% | -18.8% | -19.6% | -15.3% | -15.1% | -10.4% | -13.3% | -13.6% | -20.6% | -7.7% | -15.7% | -0.8% | 23.5% | 11.6% | -43.9% | -48.6% |
| — | -81.7% | -128.9% | -60.3% | -79.9% | -66.1% | -80.4% | -48.0% | -12.6% | +26.7% | -35.5% | +15.5% | -1509.2% | -187.6% | -166.1% | +64.2% | +98.3% | +174.2% | +659.2% | -4454.6% | — | |
| ROIC | -116.2% | -46.1% | -39.4% | -30.7% | -26.2% | -24.7% | -19.4% | -20.4% | -21.0% | -20.1% | -18.8% | -26.3% | -30.0% | -56.1% | -329.9% | -772.4% | — | — | — | — | — |
| — | -86.8% | -102.5% | -50.9% | -24.7% | -22.9% | -3.2% | +22.4% | +29.9% | +64.2% | +94.3% | +96.6% | — | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.79 | 2.02 | 0.79 | 0.91 | 0.57 | 0.40 | 0.30 | 0.24 | 0.20 | 0.17 | 0.15 | 0.14 | 0.20 | 0.18 | 0.14 | 0.15 | 0.13 | 0.13 | 0.02 | 0.16 | 0.26 |
| — | +408.6% | +168.2% | +276.6% | +187.0% | +128.2% | +95.0% | +73.9% | -1.3% | -1.9% | +7.2% | -8.8% | +54.4% | +31.3% | +777.2% | -2.3% | -49.9% | +7.1% | +146.7% | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.97 | 1.54 | 2.97 | 4.75 | 5.11 | 5.05 | 6.74 | 7.44 | 10.57 | 17.16 | 13.87 | 14.53 | 11.39 | 15.20 | 14.35 | 11.25 | 20.83 | 25.17 | 28.56 | 61.49 | 1.95 |
| — | -69.5% | -56.0% | -36.2% | -51.6% | -70.6% | -51.4% | -48.8% | -7.1% | +12.9% | -3.3% | +29.2% | -45.3% | -39.6% | -49.8% | -81.7% | +969.8% | +281.2% | +35.8% | +491.0% | — | |
| Quick Ratio | 2.97 | 1.54 | 2.97 | 4.75 | 5.11 | 5.05 | 6.74 | 7.44 | 10.57 | 17.16 | 13.87 | 14.53 | 11.39 | 15.20 | 14.35 | 11.25 | 20.83 | 25.17 | 28.56 | 61.49 | 1.95 |
| — | -69.5% | -56.0% | -36.2% | -51.6% | -70.6% | -51.4% | -48.8% | -7.1% | +12.9% | -3.3% | +29.2% | -45.3% | -39.6% | -49.8% | -81.7% | +969.8% | +281.2% | +35.8% | +491.0% | — | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | -594.95 | -15703.00 | -15333.00 | -26921.00 | -99.72 | -796.97 | -49.10 | 1467.45 | -594.00 | -1454.61 | -244.85 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying RBOT stock.
Vicarious Surgical Inc.'s current P/E is -0.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Vicarious Surgical Inc.'s business trajectory between earnings reports.